HlyA knock out yields a safer Escherichia coli A0 34/86 variant with unaffected colonization capacity in piglets

FEMS Immunology and Medical Microbiology

Volumn 48, Issue 2, 2006, Pages 257-266

  Sheshko, Valeria ^a   Hejnova, Jana ^a   Rehakova, Zuzana ^b,d   Sinkora, Jiri ^c   Faldyna, Martin ^d   Alexa, Pavel ^d   Felsberg, Jurgen ^e   Nemcova, Radomira ^f   Bomba, Alojz ^f   Sebo, Peter ^a,e  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c DAKO CZ as   (Czech Republic)

^d VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^e INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^f UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

Author keywords

Colonization; Escherichia coli; Germ free piglets; Haemolysin; Safety

Indexed keywords

HEMOLYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI AO 34 86; GENE CLUSTER; GENETIC LINKAGE; GNOTOBIOTICS; HOSPITAL INFECTION; IMMUNOMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SWINE;

ANIMALS; BACTERIAL TOXINS; CHROMOSOME MAPPING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENE DELETION; GENETIC LINKAGE; HEMOLYSIN PROTEINS; LINKAGE (GENETICS); SWINE; SWINE DISEASES; SWINE, MINIATURE;

EID: 33750065378     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00140.x     Document Type: Article

References (53)

1. Beutin L (1991) The different haemolysins of Escherichia coli. Med Microbiol Immunol (Berlin) 180: 167-182.
2. Bhakdi S, Muhly M, Korom S & Schmidt G (1990) Effects of Escherichia coli haemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J Clin Invest 85: 1746-1753.
3. Blanco J, Blanco M, Alonso MP, Blanco JE, Gonzalez EA & Garabal JI (1992) Characteristics of haemolytic Escherichia coli with particular reference to production of cytotoxic necrotizing factor type 1 (CNF1). Res Microbiol 143: 869-878.
4. Blum G, Marre R & Hacker J (1995) Properties of Escherichia coli strains of serotype O6. Infection 23: 234-236.
5. Bonacorsi SP, Clermont O, Tinsley C, Le Gall I, Beaudoin JC, Elion J, Nassif X & Bingen E (2000) Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect Immun 68: 2096-2101.
6. Boyd EF & Hartl DL (1998) Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution. J Bacteriol 180: 1159-1165.
7. Caprioli A, Falbo V, Ruggeri FM, Baldassarri L, Bisicchia R, Ippolito G, Romoli E & Donelli G (1987) Cytotoxic necrotizing factor production by haemolytic strains of Escherichia coli causing extraintestinal infections. J Clin Microbiol 25: 146-149.
8. Cavalieri SJ & Snyder IS (1982) Effect of Escherichia coli alpha-haemolysin on human peripheral leukocyte viability in vitro. Infect Immun 36: 455-461.
9. Cavalieri SJ, Bohach GA & Snyder IS (1984) Escherichia coli alpha-haemolysin: characteristics and probable role in pathogenicity. Microbiol Rev 48: 326-343.
10. Chappuis JP, Duval-Iflah Y, Ducluzeau R & Raibaud P (1985) Resistance of gnotobiotic large white and Chinese piglets to in vivo attachment of a K88ab enterotoxigenic Escherichia coli strain. Reprod Nutr Dev 25: 49-60.
11. Duval-Iflah Y, Raibaud P & Rousseau M (1981) Antagonisms among isogenic strains of Escherichia coli in the digestive tracts of gnotobiotic mice. Infect Immun 34: 957-969.
12. Duval-Iflah Y, Chappuis J.P, Ducluzeau R & Raibaud P (1983) Intraspecific interactions between Escherichia coli strains in human newborns and in gnotobiotic mice and piglets. Prog Food Nutr Sci 7: 107-116.
13. Edwards RA, Keller LH & Schifferli DM (1998) Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207: 149-157.
14. Elliott SJ, Srinivas S, Albert MJ, Alam K, Robins-Browne RM, Gunzburg ST, Mee BJ & Chang BJ (1998) Characterization of the roles of haemolysin and other toxins in enteropathy caused by alpha-haemolytic Escherichia coli linked to human diarrhea. Infect Immun 66: 2040-2051.
15. Falbo V, Famiglietti M & Caprioli A (1992) Gene block encoding production of cytotoxic necrotizing factor 1 and haemolysin in Escherichia coli isolates from extraintestinal infections. Infect Immun 60: 2182-2187.
16. Gadeberg OV, Orskov I & Rhodes JM (1983) Cytotoxic effect of an alpha-haemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro. Infect Immun 41: 358-364.
17. Grimminger F, Sibelius U, Bhakdi S, Suttorp N & Seeger W (1991) Escherichia coli haemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils. J Clin Invest 88: 1531-1539.
18. Hejnova J, Dobrindt U, Nemcova R, Rusniok C, Bomba A, Frangeul L, Hacker J, Glaser P, Sebo P & Buchrieser C (2005) Characterization of the flexible genome complement of the commensal Escherichia coli strain A0 34/86 (O83:K24:H31). Microbiology 151: 385-398.
19. Hudault S, Guignot J & Servin AL (2001) Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut 49: 47-55.
20. Issartel JP, Koronakis V & Hughes C (1991) Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation. Nature 351: 759-761.
21. Kaniga K, Delor I & Cornelis GR (1991) A wide-host-range suicide vector for improving reverse genetics in gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocolitica. Gene 109: 137-141.
22. Konig B, Konig W, Scheffer J, Hacker J & Goebel W (1986) Role of Escherichia coli alpha-haemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect Immun 54: 886-892.
23. Landraud L, Gauthier M, Fosse T & Boquet P (2000) Frequency of Escherichia coli strains producing the cytotoxic necrotizing factor (CNF1) in nosocomial urinary tract infections. Lett Appl Microbiol 30: 213-216.
24. Landraud L, Gibert M, Popoff MR, Boquet P & Gauthier M (2003) Expression of cnf1 by Escherichia coli J96 involves a large upstream DNA region including the hlyCABD operon, and is regulated by the RfaH protein. Mol Microbiol 47: 1653-1667.
25. Leece JG (1973) Effect of dietary regimen on cessation of uptake of macromolecules by piglet intestinal epithelium (closure) and transport to the blood. J Nutr 103: 751-756.
26. Lodinova R, Jouja V & Lanc A (1967) Influence of the intestinal flora on the development of immune reactions in infants. J Bacteriol 93: 797-800.
27. Lodinova R, Jouja V, Vinsova N, Vocel J & Melkova J (1980) New attempts and possibilities in prevention and treatment of intestinal coli-infections in infants. Czech Med 3: 47-58.
28. Lodinova-Zadnikova R, Tlaskalova H & Bartakova Z (1991) The antibody response in infants after colonization of the intestine with E. coli O83. Artificial colonization used as a prevention against nosocomial infections. Adv Exp Med Biol 310: 329-335.
29. Lodinova-Zadnikova R, Sonnenborn U & Tlaskalova H (1998) Probiotics and E. coli infections in man. Vet Q 20: S78-S81.
30. Lodinova-Zadnikova R, Cukrovska B & Stranak Z (2002) Effect of care in a protected environment on the occurrence of nosocomial infections, mucosal colonization of pathogenic microflora and development of indicators of immunity in premature infants. Ceska Gynekol 67: 23-28 (in Czech).
31. Lodinova-Zadnikova R, Cukrowska B & Tlaskalova-Hogenova H (2003) Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 131: 209-211.
32. Mackman N & Holland IB (1984) Functional characterization of a cloned haemolysin determinant from E coli of human origin, encoding information for the secretion of a 107K polypeptide. Mol Gen Genet 196: 129-134.
33. Mackman N, Nicaud JM, Gray L & Holland IB (1985) Genetical and functional organisation of the Escherichia coli haemolysin determinant 2001. Mol Gen Genet 201: 282-288.
34. Mandel L (1996) Manipulation of animals under germ-free conditions. Immunology Methods Manual (Lefkovits I, ed), Gnotobiotic Models. Tlaskalová H, Šterzl J (selection eds) pp. 1531-1535. Academic Press, New York.
35. Manoil C & Beckwith J (1985) TnphoA: a transposon probe for protein export signals. Proc Natl Acad Sci USA 82: 8129-8133.
36. May AK, Sawyer RG, Gleason T, Whitworth A & Pruett TL (1996) In vivo cytokine response to Escherichia coli alpha-haemolysin determined with genetically engineered haemolytic and nonhaemolytic E. coli variants. Infect Immun 64: 2167-2171.
37. Miller VL & Mekalanos JJ (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170: 2575-2583.
38. Moxley RA, Berberov EM, Francis DH, Xing J, Moayeri M, Welch RA, Baker DR & Barletta RG (1998) Pathogenicity of an enterotoxigenic Escherichia coli haemolysin (hlyA) mutant in gnotobiotic piglets. Infect Immun 66: 5031-5035.
39. Nicaud JM, Mackman N, Gray L & Holland IB (1985) Characterisation of HlyC and mechanism of activation and secretion of haemolysin from E. coli 2001. FEBS Lett 187: 339-344.
40. Nowrouzian FL, Wold AE & Adlerberth I (2005) Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J Infect Dis 191: 1078-1083.
41. Opal SM, Cross AS, Gemski P & Lyhte LW (1990) Aerobactin and alpha-haemolysin as virulence determinants in Escherichia coli isolated from human blood, urine, and stool. J Infect Dis 161: 794-796.
42. Portrait V, Gendron-Gaillard S, Cottenceau G & Pons AM (1999) Inhibition of pathogenic Salmonella enteritidis growth mediated by Escherichia coli microcin J25 producing strains. Can J Microbiol 45: 988-994.
43. Russo TA, Davidson BA, Genagon SA, Warholic NM, Macdonald U, Pawlicki PD, Beanan JM, Olson R, Holm BA & Knight PR III (2005) E. coli virulence factor haemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. Am J Physiol Lung Cell Mol Physiol 289: L207-216.
44. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA & Barrell B (2000) Artemis: sequence visualization and annotation. Bioinformatics 16: 944-955.
45. Sanger F, Nicklen S & Coulson AR (1992) DNA sequencing with chain-terminating inhibitors 1977. Biotechnology 24: 104-108.
46. Sinkora J, Rehakova Z, Sinkora M, Cukrowska B, Tlaskalova-Hogenova H, Bianchi AT & De Geus B (1998) Expression of CD2 on porcine B lymphocytes. Immunology 95: 443-449.
47. Svoboda M, Drabek J, Krejci J, Rehakova Z & Faldyna M (2004) Impairment of the peripheral lymphoid compartment in irondeficient piglets. J Vet Med B Infect Dis Vet Public Health 51: 231-237.
48. 2+ oscillations in renal epithelial cells. Nature 405: 694-697.
49. Wagner W, Vogel M & Goebel W (1983) Transport of haemolysin across the outer membrane of Escherichia coli requires two functions. J Bacteriol 154: 200-210.
50. Wandersman C & Delepelaire P (1990) TolC, an Escherichia coli outer membrane protein required for haemolysin secretion. Proc Natl Acad Sci USA 87: 4776-4780.
51. Welch RA, Dellinger EP, Minshew B & Falkow S (1981) Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature 294: 665-667.
52. Westrom B, Svendsen J & Tagesson C (1984) Intestinal permeability to polyethyleneglycol 600 in relation to macromolecular 'closure' in the neonatal pig. Gut 25: 520-525.
53. Wold AE, Caugant DA, Lidin-Janson G, de Man P & Svanborg C (1992) Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. J Infect Dis 165: 46-52.